WW250117P17500
- 12.60
- 0.000.00%
WW International Newsroom
Craig-Hallum Maintains WW International(WW.US) With Hold Rating
Craig-Hallum Sticks to Its Hold Rating for WW International (WW)
Morgan Stanley Maintains WW International(WW.US) With Hold Rating, Maintains Target Price $1.2
Morgan Stanley Maintains WW International(WW.US) With Hold Rating, Maintains Target Price $1.2
Barclays Maintains WW International(WW.US) With Sell Rating, Maintains Target Price $0.75
Barclays Maintains WW International(WW.US) With Sell Rating, Maintains Target Price $0.75
Barclays Keeps Their Sell Rating on WW International (WW)
Morgan Stanley Maintains WW International(WW.US) With Hold Rating, Maintains Target Price $1.2
Cautious Hold Rating on WW International Amidst Uncertain Growth Prospects and Market Challenges
WW International Analyst Ratings
Barclays Maintains Underweight on WW International, Maintains $0.75 Price Target
Analysts Reiterate Negative Outlook on WeightWatchers (NASDAQ:WW) Stock
Barclays Maintains WW International(WW.US) With Sell Rating, Maintains Target Price $0.75
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications
Morgan Stanley Maintains WW International(WW.US) With Hold Rating, Maintains Target Price $1.2
WW International: Strategic Shift Amid Market Challenges – A Balanced Hold Rating
Barclays Maintains WW International(WW.US) With Sell Rating, Maintains Target Price $0.75
Craig-Hallum Maintains WW International(WW.US) With Hold Rating, Announces Target Price $1
Hold Rating on WW International Amid New Semaglutide Offering and Optimistic Revenue Projections
Analyzing Risks and Margins: A Sell Rating for WW International's New Semaglutide Venture